{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:30:33Z","timestamp":1781659833811,"version":"3.54.5"},"reference-count":39,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"DOI":"10.61622\/rbgo\/2025rbgo21","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:55:17Z","timestamp":1747241717000},"source":"Crossref","is-referenced-by-count":4,"title":["Letrozole and clomiphene versus letrozole alone for ovulation induction in women with PCOS: a systematic review and meta-analysis"],"prefix":"10.61622","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2329-8575","authenticated-orcid":false,"given":"Karine","family":"Eskandar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4704-2318","authenticated-orcid":false,"given":"Juliana Almeida","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-9990","authenticated-orcid":false,"given":"Sandro Augusto","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9278-6795","authenticated-orcid":false,"given":"Matheus Pedrotti","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7870-2915","authenticated-orcid":false,"given":"Ana Isabela de Araujo","family":"Zotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-8346","authenticated-orcid":false,"given":"Yasmin Jardim Meirelles","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-4206","authenticated-orcid":false,"given":"Andrea Mora de Marco","family":"Novellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","reference":[{"key":"key20250514165510_B1","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","unstructured":"1 Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. doi: 10.1038\/nrdp.2016.57","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"key20250514165510_B2","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","unstructured":"2 Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-55. doi: 10.1093\/humrep\/dew218","journal-title":"Hum Reprod"},{"issue":"2","key":"key20250514165510_B3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","unstructured":"3 March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544-51. doi: 10.1093\/humrep\/dep399","journal-title":"Hum Reprod"},{"issue":"6","key":"key20250514165510_B4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","unstructured":"4 Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-9. doi: 10.1210\/jc.2003-032046","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20250514165510_B5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0015-0282(16)55795-1","article-title":"Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome","volume":"59","author":"Kettel","year":"1993","unstructured":"5 Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril. 1993;59(3):532-8.","journal-title":"Fertil Steril"},{"issue":"1","key":"key20250514165510_B6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14647270701689670","article-title":"Oral agents for ovulation induction--clomiphene citrate versus aromatase inhibitors","volume":"11","author":"Homburg","year":"2008","unstructured":"6 Homburg R. Oral agents for ovulation induction--clomiphene citrate versus aromatase inhibitors. Hum Fertil (Camb). 2008;11(1):17-22. doi: 10.1080\/14647270701689670","journal-title":"Hum Fertil (Camb)"},{"issue":"6","key":"key20250514165510_B7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.humrep.a137165","article-title":"Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth","volume":"5","author":"Gonen","year":"1990","unstructured":"7 Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod. 1990;5(6):670-4. doi: 10.1093\/oxfordjournals.humrep.a137165","journal-title":"Hum Reprod"},{"issue":"3","key":"key20250514165510_B8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0015-0282(16)54541-5","article-title":"Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles","volume":"56","author":"Randall","year":"1991","unstructured":"8 Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991;56(3):465-8. doi: 10.1016\/s0015-0282(16)54541-5","journal-title":"Fertil Steril"},{"issue":"4","key":"key20250514165510_B9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.fertnstert.2011.07.1092","article-title":"Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome","volume":"96","author":"Wallace","year":"2011","unstructured":"9 Wallace KL, Johnson V, Sopelak V, Hines R. Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome. Fertil Steril. 2011;96(4):1051-6. doi: 10.1016\/j.fertnstert.2011.07.1092","journal-title":"Fertil Steril"},{"issue":"1","key":"key20250514165510_B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/147323000603400109","article-title":"Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation","volume":"34","author":"Atay","year":"2006","unstructured":"10 Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res. 2006;34(1):73-6. doi: 10.1177\/147323000603400109","journal-title":"J Int Med Res"},{"key":"key20250514165510_B11","first-page":"808","volume-title":"Goodman & Gilman's: the pharmacological basis of therapeutics","author":"Levin","year":"2017","unstructured":"11 Levin ER, Vitek WS, Hammes SR. Estrogens, progestins, and the female reproductive tract. In: Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman & Gilman's: the pharmacological basis of therapeutics. 13th ed. New York: McGraw-Hill Education; 2017. p. 808-36.","edition":"13th ed."},{"issue":"3","key":"key20250514165510_B12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","unstructured":"12 Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364-79. doi: 10.1016\/j.fertnstert.2018.05.004","journal-title":"Fertil Steril"},{"key":"key20250514165510_B13","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4","author":"Higgins","year":"2023","unstructured":"13 Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.4. Chichester: Wiley; 2023 [cited 2024 May 12]. Available from: https:\/\/training.cochrane.org\/handbook\/archive\/v6.4"},{"issue":"71","key":"key20250514165510_B14","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","unstructured":"14 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. doi: 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"key20250514165510_B15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","unstructured":"15 Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;l4898. doi: 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"key20250514165510_B16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","unstructured":"16 Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;i4919. doi: 10.1136\/bmj.i4919","journal-title":"BMJ"},{"issue":"7","key":"key20250514165510_B17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","unstructured":"17 Shi J, Luo D, Wan X, Liu Y, Liu J, Bian Z, et al. Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat Methods Med Res. 2023;32(7):1338-60. doi: 10.1177\/09622802231172043","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"key20250514165510_B18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","unstructured":"18 Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785-805. doi: 10.1177\/0962280216669183","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"key20250514165510_B19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","unstructured":"19 Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. doi: 10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"key20250514165510_B20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta\u2010analysis","volume":"21","author":"Higgins","year":"2002","unstructured":"20 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta\u2010analysis. Stat Med. 2002;21(11):1539-58. doi: 10.1002\/sim.1186","journal-title":"Stat Med"},{"issue":"3","key":"key20250514165510_B21","doi-asserted-by":"crossref","first-page":"571.e1","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia","year":"2019","unstructured":"21 Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2019;111(3):571-578.e1. doi: 10.1016\/j.fertnstert.2018.11.030","journal-title":"Fertil Steril"},{"issue":"4","key":"key20250514165510_B22","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2024.07.276","article-title":"Randomized controlled trial of Combined Letrozole and Clomiphene (CLC II) versus letrozole monotherapy for women with anovulation","volume":"122","author":"Mejia","year":"2024","unstructured":"22 Mejia RB, Summers KM, Kresowik J, Cooney LG, Mancuso AC, Capper EA, et al. Randomized controlled trial of Combined Letrozole and Clomiphene (CLC II) versus letrozole monotherapy for women with anovulation. Fertil Steril. 2024;122(4 Suppl):e75. doi: 10.1016\/j.fertnstert.2024.07.276","journal-title":"Fertil Steril"},{"issue":"1","key":"key20250514165510_B23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ijgo.14476","article-title":"A triple-blind, randomized controlled trial, comparing combined letrozole and clomiphene versus only letrozole for ovulation induction in women with polycystic ovarian syndrome","volume":"161","author":"Panda","year":"2023","unstructured":"23 Panda SR, Sharmila V, Kalidoss VK, Hota S. A triple-blind, randomized controlled trial, comparing combined letrozole and clomiphene versus only letrozole for ovulation induction in women with polycystic ovarian syndrome. Int J Gynaecol Obstet. 2023;161(1):63-70. doi: 10.1002\/ijgo.14476","journal-title":"Int J Gynaecol Obstet"},{"issue":"225","key":"key20250514165510_B24","first-page":"103","article-title":"[A comparison between the effects of letrozole in combination with clomiphene and letrozole alone on ovulation and pregnancy in infertile patients with polycystic ovarian syndrome: a clinical trial study]","volume":"33","author":"Zamaniyan","year":"2023","unstructured":"24 Zamaniyan M, Razian K, Peyvandi S, Moosazadeh M, Hamedi M, Zahedi M, et al. [A comparison between the effects of letrozole in combination with clomiphene and letrozole alone on ovulation and pregnancy in infertile patients with polycystic ovarian syndrome: a clinical trial study]. J Mazandaran Univ Med Sci. 2023;33(225):103-15. Iranian","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"5","key":"key20250514165510_B25","article-title":"Assessment of fertility outcomes following combined clomiphene and letrozole versus letrozole therapy for the treatment of polycystic ovarian syndrome subfertility","volume":"15","author":"Sharma","year":"2023","unstructured":"25 Sharma P, Chandra R, Sarkar A, Jindal S, Sharma A, Sharma JC, et al. Assessment of fertility outcomes following combined clomiphene and letrozole versus letrozole therapy for the treatment of polycystic ovarian syndrome subfertility. Cureus. 2023;15(5):e38886. doi: 10.7759\/cureus.38886","journal-title":"Cureus"},{"issue":"5","key":"key20250514165510_B26","first-page":"188","article-title":"Effect on ovulation induction by letrozole alone or in combination with clomiphene","volume":"15","author":"Mirajkar","year":"2023","unstructured":"26 Mirajkar V. Effect on ovulation induction by letrozole alone or in combination with clomiphene. Intl J Pharm Clin Res. 2023;15(5):188-97.","journal-title":"Intl J Pharm Clin Res"},{"issue":"1","key":"key20250514165510_B27","first-page":"41","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"27 Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;19(1):41-7. doi: 10.1093\/humrep\/deh098","journal-title":"Fertil Steril"},{"issue":"6","key":"key20250514165510_B28","first-page":"E194","article-title":"738: aromatase inhibitors in gynecologic practice","volume":"131","author":"ACOG Committee Opinion No","year":"2018","unstructured":"28 ACOG Committee Opinion No. 738: aromatase inhibitors in gynecologic practice. Obstet Gynecol. 2018;131(6):E194\u20139. doi: 10.1097\/AOG.0000000000002640","journal-title":"Obstet Gynecol"},{"issue":"6","key":"key20250514165510_B29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/humupd\/dmz029","article-title":"First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis","volume":"25","author":"Wang","year":"2019","unstructured":"29 Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update. 2019;25(6):717-32. doi: 10.1093\/humupd\/dmz029","journal-title":"Hum Reprod Update"},{"issue":"9","key":"key20250514165510_B30","article-title":"Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome","volume":"9","author":"Franik","year":"2022","unstructured":"30 Franik S, Le QK, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2022;9(9):CD010287. doi: 10.1002\/14651858.CD010287.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"key20250514165510_B31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/AOG.0000000000005070","article-title":"Letrozole compared with clomiphene citrate for polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"141","author":"Liu","year":"2023","unstructured":"31 Liu Z, Geng Y, Huang Y, Hu R, Li F, Song Y, et al. Letrozole compared with clomiphene citrate for polycystic ovarian syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2023;141(3):523-34. doi: 10.1097\/AOG.0000000000005070","journal-title":"Obstet Gynecol"},{"issue":"1","key":"key20250514165510_B32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.fertnstert.2022.09.018","article-title":"Extending letrozole treatment duration is effective in inducing ovulation in women with polycystic ovary syndrome and letrozole resistance","volume":"119","author":"Zhu","year":"2023","unstructured":"32 Zhu X, Fu Y. Extending letrozole treatment duration is effective in inducing ovulation in women with polycystic ovary syndrome and letrozole resistance. Fertil Steril. 2023;119(1):107-13. doi: 10.1016\/j.fertnstert.2022.09.018","journal-title":"Fertil Steril"},{"key":"key20250514165510_B33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40834-019-0102-4","article-title":"Ovulation rates in a stair-step protocol with letrozole vs clomiphene citrate in patients with polycystic ovarian syndrome","volume":"4","author":"Thomas","year":"2019","unstructured":"33 Thomas S, Woo I, Ho J, Jones T, Paulson R, Chung K, et al. Ovulation rates in a stair-step protocol with letrozole vs clomiphene citrate in patients with polycystic ovarian syndrome. Contracept Reprod Med. 2019;4:20. doi: 10.1186\/s40834-019-0102-4","journal-title":"Contracept Reprod Med"},{"key":"key20250514165510_B34","doi-asserted-by":"crossref","first-page":"532692","DOI":"10.3389\/fendo.2020.532692","article-title":"Letrozole versus clomiphene citrate and natural cycle: endometrial receptivity during implantation window in women with polycystic ovary syndrome","volume":"11","author":"Wang","year":"2021","unstructured":"34 Wang L, Lv S, Li F, Bai E, Yang X. Letrozole versus clomiphene citrate and natural cycle: endometrial receptivity during implantation window in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;11:532692. doi: 10.3389\/fendo.2020.532692","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key20250514165510_B35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/uog.18933","article-title":"Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis","volume":"51","author":"Gadalla","year":"2018","unstructured":"35 Gadalla MA, Huang S, Wang R, Norman RJ, Abdullah SA, El Saman AM, et al. Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(1):64-76. doi: 10.1002\/uog.18933","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"key20250514165510_B36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0015-0282(02)03241-7","article-title":"A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women","volume":"78","author":"Fisher","year":"2002","unstructured":"36 Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril. 2002;78(2):280-5. doi: 10.1016\/s0015-0282(02)03241-7","journal-title":"Fertil Steril"},{"issue":"8","key":"key20250514165510_B37","first-page":"36","article-title":"Pregnancy outcomes in patients with anovulatory infertility in different ovulation induction programs","volume":"83","author":"Lin","year":"2021","unstructured":"37 Lin S. Pregnancy outcomes in patients with anovulatory infertility in different ovulation induction programs. Indian J Pharm Sci. 2021;83(8):36-40.","journal-title":"Indian J Pharm Sci"},{"key":"key20250514165510_B38","article-title":"To compare whether combination of letrozole and clomiphene is more effective than letrozole alone for egg development in women who are unable to conceive due to PCOS (improper egg development)","year":"2020","unstructured":"38 To compare whether combination of letrozole and clomiphene is more effective than letrozole alone for egg development in women who are unable to conceive due to PCOS (improper egg development). International Clinical Trials Registry Platform; 2020 [cited 2024 Nov 3]. CTRI\/2020\/07\/026263. Available from: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2020\/07\/026263","journal-title":"International Clinical Trials Registry Platform"},{"key":"key20250514165510_B39","article-title":"Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone","year":"2024","unstructured":"39 Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone. ClinicalTrials.gov; 2024 [cited 2024 Nov 3]. NCT06507332. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT06507332","journal-title":"ClinicalTrials.gov"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:55:26Z","timestamp":1747241726000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/letrozole-and-clomiphene-versus-letrozole-alone-for-ovulation-induction-in-women-with-pcos-a-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"alternative-id":["10.61622\/rbgo\/2025rbgo21"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2025rbgo21","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e-rbgo21"}}